Koch CJ - Search Results

1

Detection of hypoxia in human squamous cell carcinoma by EF5 binding.

Evans SM, Hahn S, Pook DR, Jenkins WT, Chalian AA, Zhang P, Stevens C, Weber R, Weinstein G, Benjamin I, Mirza N, Morgan M, Rubin S, McKenna WG, Lord EM, Koch CJ. Evans SM, et al. Among authors: koch cj. Cancer Res. 2000 Apr 1;60(7):2018-24. Cancer Res. 2000. PMID: 10766193 Clinical Trial.

2

2-Nitroimidazole (EF5) binding predicts radiation resistance in individual 9L s.c. tumors.

Evans SM, Jenkins WT, Joiner B, Lord EM, Koch CJ. Evans SM, et al. Among authors: koch cj. Cancer Res. 1996 Jan 15;56(2):405-11. Cancer Res. 1996. PMID: 8542599

3

Biodistribution of the nitroimidazole EF5 (2-[2-nitro-1H-imidazol-1-yl]-N-(2,2,3,3,3-pentafluoropropyl) acetamide) in mice bearing subcutaneous EMT6 tumors.

Laughlin KM, Evans SM, Jenkins WT, Tracy M, Chan CY, Lord EM, Koch CJ. Laughlin KM, et al. Among authors: koch cj. J Pharmacol Exp Ther. 1996 May;277(2):1049-57. J Pharmacol Exp Ther. 1996. PMID: 8627516

4

Direct relationship between radiobiological hypoxia in tumors and monoclonal antibody detection of EF5 cellular adducts.

Lee J, Siemann DW, Koch CJ, Lord EM. Lee J, et al. Among authors: koch cj. Int J Cancer. 1996 Jul 29;67(3):372-8. doi: 10.1002/(SICI)1097-0215(19960729)67:3<372::AID-IJC11>3.0.CO;2-A. Int J Cancer. 1996. PMID: 8707411

5

Evaluation of the concept of "hypoxic fraction" as a descriptor of tumor oxygenation status.

Evans SM, Jenkins WT, Shapiro M, Koch CJ. Evans SM, et al. Among authors: koch cj. Adv Exp Med Biol. 1997;411:215-25. doi: 10.1007/978-1-4615-5865-1_26. Adv Exp Med Biol. 1997. PMID: 9269430

6

Tamoxifen induces hypoxia in MCF-7 xenografts.

Evans SM, Koch CJ, Laughlin KM, Jenkins WT, Van Winkle T, Wilson DF. Evans SM, et al. Among authors: koch cj. Cancer Res. 1997 Nov 15;57(22):5155-61. Cancer Res. 1997. PMID: 9371518

7

Co-localization of hypoxia and apoptosis in irradiated and untreated HCT116 human colon carcinoma xenografts.

Koch CJ, Chasan JE, Jenkins WT, Chan CY, Laughlin KM, Evans SM. Koch CJ, et al. Adv Exp Med Biol. 1998;454:611-8. doi: 10.1007/978-1-4615-4863-8_72. Adv Exp Med Biol. 1998. PMID: 9889941

8

Hypoxia-mediated apoptosis from angiogenesis inhibition underlies tumor control by recombinant interleukin 12.

Gee MS, Koch CJ, Evans SM, Jenkins WT, Pletcher CH Jr, Moore JS, Koblish HK, Lee J, Lord EM, Trinchieri G, Lee WM. Gee MS, et al. Among authors: koch cj. Cancer Res. 1999 Oct 1;59(19):4882-9. Cancer Res. 1999. PMID: 10519400

9

Hypoxia and necrosis in rat 9L glioma and Morris 7777 hepatoma tumors: comparative measurements using EF5 binding and the Eppendorf needle electrode.

Jenkins WT, Evans SM, Koch CJ. Jenkins WT, et al. Among authors: koch cj. Int J Radiat Oncol Biol Phys. 2000 Mar 1;46(4):1005-17. doi: 10.1016/s0360-3016(99)00342-9. Int J Radiat Oncol Biol Phys. 2000. PMID: 10705024 Free article.

10

Depletion of tumor oxygenation during photodynamic therapy: detection by the hypoxia marker EF3 [2-(2-nitroimidazol-1[H]-yl)-N-(3,3,3-trifluoropropyl)acetamide ].

Busch TM, Hahn SM, Evans SM, Koch CJ. Busch TM, et al. Among authors: koch cj. Cancer Res. 2000 May 15;60(10):2636-42. Cancer Res. 2000. PMID: 10825135

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

225 results

Search Page

Filters